http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108210497-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2016-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108210497-B |
| titleOfInvention | Application of compound MLN4924 in preparation of bunyaviridae phlebovirus inhibitor |
| abstract | The invention discloses an application of a compound MLN4924 in preparing a bunyaviridae phlebovirus inhibitor, wherein the compound MLN4924 has a structure shown in a formula (I): experiments prove that the compound MLN4924 can inhibit the fever-associated thrombocytopenia syndrome virus or Sicily phlebovirus in phlebovirus of bunyaviridae. The invention can activate interferon antiviral approach when host cell is infected by virus by inhibiting RIG-I ubiquitination degradation mediated by SFTSV NSs, and obviously inhibit virus replication and proliferation. |
| priorityDate | 2016-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.